Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 2Thoracic 1Lymphoid 1

Conditions

Hodgkin Disease 1

Interventions

Cyclophosphamide 166Rituximab 155Specimen Handling 114Biopsy 91Magnetic Resonance Spectroscopy 90Vincristine 85Doxorubicin 79Prednisone 78fludarabine 69venetoclax 67obinutuzumab 62ibrutinib 54Lenalidomide 53Dexamethasone 53Cytarabine 47Methotrexate 44acalabrutinib 42Etoposide 41CT-P10 40blinatumomab 38fludarabine phosphate 34Bendamustine Hydrochloride 34prednylidene 32Gemcitabine 32deltacortene 31Calcium Dobesilate 30zanubrutinib 29pembrolizumab 29glofitamab 28Nivolumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
High-Intensity Interval Training × Lymphoid × 90 days × Clear all
NCT07222345 2026-06-04

Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma

St. Jude Children's Research Hospital

Phase NA Recruiting
20 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡